Jennifer Sukawaty

Aug 11, 2023 | brunswickgroup.com | Charis Gresser |Tanisha Carino |Jennifer Sukawaty |Kate Larsen

Interview with incoming Director of the UK Dementia Research Institute Professor Siddharthan ChandranNew disease-modifying drugs that target sticky amyloid plaques in the brain have been hailed as a turning-point in treating Alzheimer’s. Yet important questions remain over access, identifying those patients who will benefit, developing improved healthcare infrastructure and monitoring potentially dangerous side effects.

Jul 5, 2023 | brunswickgroup.com | Charis Gresser |Jennifer Sukawaty

Kate LarsenAssociate, San Francisco I represented Brunswick’s San Francisco office at the two-day conference in Los Angeles, where it was made clear that nobody in the healthcare space is waiting for certainty to seek solutions for a healthier future. From AI-enabled stethoscopes and male birth control to the menopause market, innovation was in full swing.